Pipeline

From Data to Drug Candidates in Months Not Years

Next-generation, multi-target drug candidates for safe, more effective patient outcomes

Next-generation, multi-target drug candidates for safe, more effective patient outcomes.

2023

In-Silico

Neurological Disorder #1

Metabolic Disorder #1

Neurological Disorder #2

Cancer #1

Initial Synthesis

PTSD

A novel approach to Post-Traumatic Stress Disorder.

In-Vitro

SUD ― Cocaine

Combatting opioid use through targeted therapies.

In-Vivo

OUD ― Fentanyl

Combatting opioid use through targeted therapies.

IND

2024

Research & Data

Autoimmune Disease #1

Metabolic Disorder #2

Metabolic Disorder #3

Neurological Disorder #3

Autoimmmune Disease #2

Neurological Disorder #4

In-Silico

Initial Synthesis

In-Vitro

In-Vivo

IND

2023

OUD ― Fentanyl

Combatting opioid use through targeted therapies.

SUD ― Cocaine

Advancing innovative treatments to address cocaine substance use disorder.

PTSD

A novel approach to Post-Traumatic Stress Disorder.

Neurological Disorder #1

Metabolic Disorder #1

Neurological Disorder #2

Cancer #1

Research & Data

In-Silico

Initial Synthesis

In-Vitro

In-Vivo

IND

2024

Autoimmune Disease #1

Metabolic Disorder #2

Metabolic Disorder #3

Neurological Disorder #3

Autoimmmune Disease #2

Neurological Disorder #4

Research & Data

In-Silico

Initial Synthesis

In-Vitro

In-Vivo

IND

Contacts

Join Us in Transforming Medicine Through Advanced AI

We're always on the lookout for like-minded partners committed to making healthcare better, more efficient, and safer. Reach out today to see how our specialized AI solutions can be tailored to your needs.